CART Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction MSBIP Q1 2026 Earnings Strong EPS Beat Amidst Flat Stock Reaction KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports WiderThanExpected Loss Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment ESPR Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed